Admission Date:  [**2135-12-29**]       Discharge Date:  [**2136-4-20**]  Date of Birth:   [**2135-12-29**]       Sex:  F   HISTORY OF PRESENT ILLNESS:  Baby girl [**Known lastname 38329**] [**Known lastname 38330**]-[**Known lastname **], triplet one, delivered at 24-5/7 weeks gestation, weighing 709 g, and was admitted to the Intensive Care Nursery for management of extreme prematurity.
The mother is a 27-year-old gravida 2, para 1 (now 3) woman with spontaneous triplet gestation.
Prenatal screens included blood type O positive, antibody screen negative, Rubella immune, rapid plasma reagin nonreactive, hepatitis B surface antigen negative, and group B strep unknown.
Delivery was by cesarean section under spinal anesthesia for worsening pregnancy-induced hypertension.
This triplet was active at delivery and was given mask CPAP and then was intubated in the delivery room secondary to extreme prematurity.
No significant bruising.
Lungs with crackles and retracting.
Abdomen without hepatosplenomegaly or masses.
Genitalia consistent with extreme prematurity.
RESPIRATORY:  Received two doses of Survanta for respiratory distress syndrome, initially requiring conventional ventilatory support, then transitioning to high frequency oscillatory ventilation between day 3 and 12 of life.
Chronic lung disease was treated with Diuril 40 mg/kg per day divided b.i.d.
She also received caffeine citrate for apnea of prematurity.
A baseline chest radiograph prior to discharge shows resolving diffuse chronic lung changes but no focal parenchymal infiltrates..   2.
CARDIOVASCULAR:  [**Known lastname 38329**] treated for low mean blood pressures following birth with a normal saline bolus, then dopamine infusion with maximum support 2.5 mcg/kg per minute in the first 24 hours.
She also received a course of Indocin for a presumed patent ductus arteriosus within the first 48 hours of life.
KCL supplements have been given due to diuretic-associated electrolyte losses.
INFECTIOUS DISEASE:  Received 48 hours of ampicillin and gentamicin following birth for rule out sepsis with a normal complete blood count and negative blood cultures.
On day of life 22, she also started a 10-day course of gentamicin and cefotaxime for tracheitis pneumonia with culture positive, tracheal aspirate for Klebsiella pneumoniae.
NEUROLOGY:  Has had multiple head ultrasounds since birth with the last at 36 weeks gestation; all were within normal limits.
No bleeding or periventricular leukomalacia.
CONDITION AT DISCHARGE:  A 113-day-old; now 40-6/7 weeks corrected age, triplet #1 with chronic lung disease, on diuretic therapy.
Feeds:  Ad lib demand breast feeding or expressed breast milk or Enfamil-20 with iron.
State Newborn Screens:  Multiple state newborn screens have been done secondary to gestational age; and all have been within normal limits.
(2) Born between 32 and 35 weeks with plans for day care during respiratory syncytial virus season, with a smoker in the household, or with preschool siblings; and (3) With chronic lung disease.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age, the family and other care givers should be considered for immunization against influenza to protect the infant.
Respiratory distress syndrome; resolved.
Chronic lung disease.
Klebsiella pneumoniae/tracheitis pneumoniae.
Anemia of prematurity.
